2 Notes on the scope of the guidance
NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.
The guideline offers best practice advice on the care of adults who have a clinical working diagnosis of COPD including chronic bronchitis, emphysema, and chronic airflow limitation/obstruction. The guideline is relevant to primary and secondary healthcare professionals who have direct contact with patients with COPD, and make decisions about their care.
The guideline covers diagnostic criteria and identification of early disease. The guideline also makes recommendations on the management of people with stable COPD, exacerbations and preventing progression of the disease.
The guideline does not cover the management of people with asthma, bronchopulmonary dysplasia and bronchiectasis, nor does it cover children.
How this guideline was developed
NICE commissioned the National Clinical Guideline Centre for Acute and Chronic Conditions to develop this guideline update. The Centre established a guideline development group (see appendix A), which reviewed the evidence and developed the recommendations. An independent guideline review panel oversaw the development of the guideline (see appendix B).
There is more information about how NICE clinical guidelines are developed on the NICE website. A booklet, 'How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS' is available.